Skip to main content

BET Bromodomains

Ref-Nr: TA-2252



Highly Efficient and Selective Inhibitors Targeting BET Bromodomains


BET proteins are important because they regulate both normal transcription processes as well as the transcription of oncogenes such as c-myc and Bcl-2 in various types of cancer. An efficient and selective inhibition of the BET proteins is therefore of great importance for cancer therapies. Various compounds, including benzenesulfonamide derivates are known to possess this property. However, there is a great desire for further, more selective inhibitors.

Bilder & Videos


The use of sulfoximine, sulfondiimide and sulfonimidamide derivatives allows to generate novel molecules with a stereogenic sulfur atom. The utilization of this chirality provides new, highly effective and selective BET inhibitors.


  • Novel BET inhibitors bearing a stereocenter
  • Chirality is the key to high efficacy and selectivity


Pharmaceutical Development; Oncology


  • European and US patent application pending.

  •  Proof of concept and Ongoing research


RWTH Aachen University is looking for partners for patent exploitation.

RWTH Aachen University

Marieke Sternkopf
0241 8096612
Campus-Boulevard 57
52074 Aachen


#BET inhibitor, #Sulfoximines, #Sulfondiimides, #Sulfonimidam-ides

Angebot Anbieter-Website

Kontakt | Geschäftsstelle

TransferAllianz e. V.
Christiane Bach-Kaienburg

c/o TransMIT GmbH
Kerkrader Straße 3
D-35394 Gießen